Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension

Journal of the American Society of Hypertension

Volumn 9, Issue 6, 2015, Pages 420-426.e2

  Pandey, Ambarish ^a   Raza, Fayez ^a   Velasco, Alejandro ^a   Brinker, Stephanie ^a   Ayers, Colby ^a   Das, Sandeep R ^a   Morisky, Donald E ^b   Halm, Ethan A ^a   Vongpatanasin, Wanpen ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood pressure control; Self reported adherence; Serum drug levels

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HEART RATE; HUMAN; MALE; MEASUREMENT ACCURACY; MEDICATION COMPLIANCE; MORISKY MEDICATION ADHERENCE SCALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUESTIONNAIRE; RESISTANT HYPERTENSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT REFUSAL; WHITE COAT HYPERTENSION; AGE; AREA UNDER THE CURVE; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DRUG RESISTANCE; FOLLOW UP; HYPERTENSION; MIDDLE AGED; PROCEDURES; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; COHORT STUDIES; CONFIDENCE INTERVALS; DRUG MONITORING; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84942897240     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2015.04.004     Document Type: Article

References (24)

1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008;117:e510-26.
2. Brinker S, Pandey A, Ayers C, Price A, Raheja P, Arbique D, et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J Am Coll Cardiol 2014;63:834-5.
3. Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens 2013;31:766-74.
4. Strauch B, Petrak O, Zelinka T, Rosa J, Somloova Z, Indra T, et al. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. J Hypertens 2013;31:2455-61.
5. Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J, et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart 2014;100: 855-61.
6. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009;15:59-66.
7. Ben AJ, Neumann CR, Mengue SS. The Brief Medication Questionnaire and Morisky-Green test to evaluate medication adherence. Rev Saude Publica 2012;46:279-89.
8. Prado JC Jr, Kupek E, Mion D Jr. Validity of four indirect methods to measure adherence in primary care hypertensives. J Hum Hypertens 2007;21:579-84.
9. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
10. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008;10:348-54.
11. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005;45:142-61.
12. Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate nonresponsiveness from non-adherence to recommended therapy. Hypertens Res 2011;34:87-90.
13. Chytil L, Strauch B, Cvacka J, Maresova V, Widimsky J Jr, Holaj R, et al. Determination of doxazosin and verapamil in human serum by fast LCMS/MS: application to document non-compliance of patients. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:3167-73.
14. Zeller A, Taegtmeyer A, Martina B, Battegay E, Tschudi P. Physicians' ability to predict patients' adherence to antihypertensive medication in primary care. Hypertens Res 2008;31:1765-71.
15. Zeller A, Ramseier E, Teagtmeyer A, Battegay E. Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertens Res 2008;31:2037-43.
16. Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 1996;9:719-25.
17. van Onzenoort HA, Verberk WJ, Kessels AG, Kroon AA, Neef C, van der Kuy PH, et al. Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-tomoderate hypertension. Am J Hypertens 2010;23: 149-54.
18. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther 1989;46:163-8.
19. Al Ghurair SA, Hughes CA, Simpson SH, Guirguis LM. A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model. J Clin Hypertens 2012;14:877-86.
20. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999;37:113-24.
21. Wetzels G, Nelemans P, van Wijk B, Broers N, Schouten J, Prins M. Determinants of poor adherence in hypertensive patients: development and validation of the "Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire". Patient Educ Couns 2006;64: 151-8.
22. Benson J, Britten N. Patients' views about taking antihypertensive drugs: questionnaire study. BMJ 2003; 326:1314-5.
23. Irvin MR, Shimbo D, Mann DM, Reynolds K, Krousel-Wood M, Limdi NA, et al. Prevalence and correlates of low medication adherence in apparent treatmentresistant hypertension. J Clin Hypertens 2012;14: 694-700.
24. Chung O, Vongpatanasin W, Bonaventura K, Lotan Y, Sohns C, Haverkamp W, et al. Potential costeffectiveness of therapeutic drug monitoring in patients with resistant hypertension. J Hypertens 2014;32: 2411-21.